Acerta Pharma ACE - MY - 001 : An Open label, Phase 1b Study of ACP - 196 in Subjects with Multiple Myeloma

An Open label, Phase 1b Study of ACP - 196 in Subjects with Multiple Myeloma

Acerta
Cancer
Saad Jamshed, MD
Enrolling
Denise Maracle, RN
(585) 747-4555
(585) 922 - 9146